Todayís CC | ALNY Message Board Posts

Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34656 of 34657  at  8/7/2019 3:26:37 PM  by

evernewbliss


 In response to msg 34654 by  Steve_382
view thread

Re: Todayís CC

I havenít seen this kind of firework in pps for quite sometime. It is not that all the other biotechs are participating. It is definitely related to continued growth in Onpattro sales.

Management anticipates TTR is going to be multi billion dollar market opportunity for Alnylam if they are successful to expand in wild type CM market. So I expect TTR will be a major value driver for midterm and longterm if management is correct in their guidance.

Analysts were focused on Onpattro and no one asked any questions regarding any other drugs in the pipeline except for Givosiran. So no wonder HBV or any other drugs were not discussed. We will have to wait until November to get any news on HBV or AAT02.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 125
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...